CROIX FOSSUM

Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology SAN DIEGO, CA NPI 1104351006

General Payments — all program years on this page

$692.19

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $672.12 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $597.1319
Education $74.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $20.071
2024 $672.1220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077938870 Janssen Pharmaceuticals, Inc $18.71 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078328665 Janssen Biotech, Inc. $18.73 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078329854 Janssen Biotech, Inc. $34.63 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086184042 Bayer Healthcare Pharmaceuticals Inc. $19.94 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086947839 Novartis Pharmaceuticals Corporation $20.45 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089422507 Daiichi Sankyo Inc. $20.16 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093881172 Alexion Pharmaceuticals, Inc. $20.86 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113834336 PUMA BIOTECHNOLOGY, INC. $19.76 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120867670 BeiGene USA, Inc. $28.89 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128510969 PROGENICS PHARMACEUTICALS, INC. $15.53 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137272524 INTUITIVE SURGICAL, INC. $67.36 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137307606 PharmaEssentia USA Corporation $33.29 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139446832 Astellas Pharma US Inc $74.99 12/19/2024 Education Undisputed 01/23/2026 View at CMS
1142959142 Stemline Therapeutics Inc. $21.74 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145528650 Karyopharm Therapeutics Inc. $22.52 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145873169 Deciphera Pharmaceuticals Inc. $32.20 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147258884 SERVIER PHARMACEUTICALS LLC $21.70 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149315778 Dendreon Pharmaceuticals LLC $33.79 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151422429 icotec Medical Inc. $123.23 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154821833 Pharmacosmos Therapeutics Inc. $23.64 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.